Stay updated on BS01 in Patients With Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the BS01 in Patients With Retinitis Pigmentosa Clinical Trial page.

Latest updates to the BS01 in Patients With Retinitis Pigmentosa Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- The page now includes a government-operating-status notice and directs users to official sources (cc.nih.gov, opm.gov), indicating a status update and potential processing delays. - The version is updated from v3.1.0 to v3.2.0. If there were no other substantive content changes, this reflects an update to the release/versioning rather than functional changes.SummaryDifference6%
- Check15 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantive changes to core content, pricing, or availability.SummaryDifference0.4%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.4%
- Check44 days agoChange DetectedThe web page has been updated to reflect a new facility name and location, along with significant changes in the details regarding retinitis pigmentosa, including updated criteria for visual acuity and detection capabilities. Additionally, the page now indicates that the facility is active and not recruiting.SummaryDifference13%
- Check58 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.2%
Stay in the know with updates to BS01 in Patients With Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BS01 in Patients With Retinitis Pigmentosa Clinical Trial page.